Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
WEBTOON Entertainment’s $315 Million IPO
Kirkland & Ellis advised WEBTOON Entertainment Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. WEBTOON Entertainment Inc. (“WEBTOON”...
EQT’s $3 Billion Acquisition of Perficient
Simpson Thacher & Bartlett is advising an affiliate of BPEA Private Equity Fund VIII, part of EQT on the transaction, and Kirkland & Ellis is advising...
Apax Digital Funds’ Investment in IANS Research
Kirkland & Ellis advised Apax Digital Funds on the transaction. Apax Digital Funds executed an investment in IANS Research (“IANS”), the leading provider of independent research...
Energy Capital Partners’ Combination with BridgepointEnergy Capital Partners’ Combination with Bridgepoint
Kirkland & Ellis advised Energy Capital Partners, and Simpson Thacher & Bartlett advised Bridgepoint on the deal. J.P. Morgan Cazenove and Morgan Stanley served as lead...